No abstract available
MeSH terms
-
Anticoagulants / therapeutic use*
-
Blood Coagulation Disorders / etiology*
-
Blood Coagulation Disorders / virology*
-
COVID-19 / complications*
-
Fibrin Fibrinogen Degradation Products / metabolism
-
Hospitalization
-
Humans
-
Practice Guidelines as Topic
-
SARS-CoV-2 / physiology*
-
Thrombosis / etiology
-
Thrombosis / virology
Substances
-
Anticoagulants
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D